The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery

Study limitation reported by the research below: “Anti-PS/PT antibodies and lectin pathway activity are not currently included in standard APS classification criteria; clinical adoption would require further validation.”